HomeNewsBusinessEconomyNo plan to print more currency to tide over economic slowdown: FM Nirmala Sitharaman

No plan to print more currency to tide over economic slowdown: FM Nirmala Sitharaman

Fundamentals of the economy remain strong as gradual scaling back of lockdowns, along with astute support of Atmanirbhar Bharat Mission has placed the economy firmly on the path of recovery from the second half of FY 2020-21, FM Nirmala Sitharaman told the Lok Sabha

July 26, 2021 / 13:24 IST
Story continues below Advertisement
FM Nirmala Sitaraman
FM Nirmala Sitaraman

The government does not plan to print more currency to tide over the economic slowdown brought about by the COVID-19 pandemic, Union Finance Minister Nirmala Sitharaman told the Lok Sabha on July 26.

"The fundamentals of the economy remain strong as gradual scaling back of lockdowns, along with the astute support of the Aatmanirbhar Bharat Mission has placed the economy firmly on the path of recovery from the second half of FY 2020-21," Sitharaman said in a reply to a question by Lok Sabha member Mala Roy on the state of the economy during the coronavirus pandemic.

Story continues below Advertisement

When asked "whether there is any plan to print currency to tide over the crisis", the finance minister, in her written statement, replied "no".

There have been calls from multiple quarters that the Reserve Bank of India (RBI) should print more money and the government should use that to distribute it among the people and small businesses most affected by the economic hardships caused by the pandemic, either in the form of direct income support or employment support.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show